AT-59 HIGH-DOSE MTX-BASED CHEMOTHERAPY FOR PRIMARY CNS LYMPHOMA: WITH OR WITHOUT WHOLE BRAIN RADIOTHERAPY? FINAL ANALYSIS OF G-PCNSL-SG-1

BACKGROUND: This is the final report of the G-PCNSL-SG-1 trial after a median follow-up of 81.2 months. METHODS: G-PCNSL-SG-1 (www.clinicaltrials.gov NCT00153530) had randomised immunocompetent patients with newly diagnosed PCNSL to high-dose methotrexate (HDMTX) - based chemotherapy followed by who...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Weller, Michael, Thiel, Eckhard, Martus, Peter, Möhle, Robert, Griesinger, Frank, Rauch, Michael, Roeth, Alexander, Hertenstein, Bernd, Fischer, Thomas, Hundsberger, Thomas, Mergenthaler, Hans-Günter, Junghanss, Christian, Birnbaum, Tobias, Fischer, Lars, Jahnke, Kristoph, Herrlinger, Ulrich, Pietsch, Torsten, Roth, Patrick, Bamberg, Michael, Korfel, Agnieszka
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Adult Clinical Trials
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217839/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou237.58
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars